QTI
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Ref P/B 12.79, P/S 4.41
- P/B ratio of 12.79 is excessive
- No Graham Number available due to lack of earnings
Ref Revenue Growth (YoY)
- Hyper-growth in revenue (877%)
- Inability to translate growth into profit
Ref Historical Price Performance
- 5Y Change of -95.3%
- 6M Change of -78.7%
Ref Piotroski F-Score
- Current Ratio 2.81
- Piotroski F-Score 1/9
- ROA -19.05%
Ref Dividend Yield N/A
- No dividend paid
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for QTI and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
QTI
QT Imaging Holdings, Inc.
Primary
|
-95.3% | -95.6% | -34.0% | -78.7% | +0.9% | +0.3% |
|
PARK
Park Dental Partners, Inc.
Peer
|
+75.8% | +75.8% | +75.8% | +75.8% | +5.4% | +1.2% |
|
OKYO
OKYO Pharma Limited
Peer
|
-54.4% | +32.0% | +47.3% | -20.3% | -1.8% | +3.8% |
|
AMWL
American Well Corporation
Peer
|
-99.3% | -93.4% | -55.6% | -45.6% | +6.1% | +3.4% |
|
GOSS
Gossamer Bio, Inc.
Peer
|
-95.6% | -66.2% | -57.8% | -85.5% | -26.7% | +0.4% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
QTI
QT Imaging Holdings, Inc.
|
BEARISH | $83.45M | - | -% | -111.4% | $6.93 | |
|
PARK
Park Dental Partners, Inc.
|
NEUTRAL | $81.36M | - | -4.1% | -0.1% | $18.02 | Compare |
|
OKYO
OKYO Pharma Limited
|
BEARISH | $86.59M | - | -% | -% | $1.65 | Compare |
|
AMWL
American Well Corporation
|
BEARISH | $79.73M | - | -37.0% | -42.8% | $4.87 | Compare |
|
GOSS
Gossamer Bio, Inc.
|
BEARISH | $87.21M | - | -% | -% | $0.37 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-20 | KLOCK JOHN C JR. | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award | 3,500 | - |
| 2026-03-20 | GREENE JAMES S | Director | Stock Award | 3,500 | - |
| 2026-03-20 | KATZ AVISHAY S. | Chairman of the Board | Stock Award | 3,500 | - |
| 2026-03-20 | JENNINGS JAY WALTER | Chief Financial Officer | Stock Award | 2,800 | - |
| 2026-03-20 | DINU RALUCA | Chief Executive Officer | Stock Award | 519,500 | - |
| 2026-03-20 | TAYLOR ROSS | Director | Stock Award | 3,500 | - |
| 2026-03-20 | DICKSON DANIEL H | Director | Stock Award | 3,500 | - |
| 2026-03-20 | WEINER ZEEV | Director | Stock Award | 3,500 | - |
| 2026-03-17 | WEINER ZEEV | Director | Option Exercise | 23,054 | $48,217 |
| 2026-01-22 | KATZ AVISHAY S. | Chairman of the Board | Purchase | 24,107 | $155,008 |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
Past News Coverage
Recent headlines mentioning QTI from our newsroom.